| RS63751704 |
MLH1
|
Health Risk |
Pathogenic |
Lynch syndrome, Lynch syndrome |
| RS63751705 |
MLH1
|
Health Risk |
Pathogenic |
Lynch syndrome, Hereditary cancer-predisposing syndrome |
| RS63751707 |
MLH1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS63751709 |
MLH1
|
Health Risk |
Pathogenic |
Lynch syndrome, Hereditary cancer-predisposing syndrome |
| RS63751710 |
MLH1
|
Health Risk |
Pathogenic |
Lynch syndrome, Lynch syndrome |
| RS63751711 |
MLH1
|
Health Risk |
Likely pathogenic |
Lynch syndrome, Hereditary cancer-predisposing syndrome |
| RS63751712 |
MSH2
|
Health Risk |
Pathogenic |
Lynch syndrome, Hereditary cancer-predisposing syndrome |
| RS63751713 |
MLH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS63751715 |
MLH1
|
Health Risk |
Pathogenic |
Lynch syndrome, Hereditary cancer-predisposing syndrome |
| RS63751891 |
MLH1
|
Health Risk |
Pathogenic |
Lynch syndrome, Lynch syndrome |
| RS63751892 |
MLH1
|
Health Risk |
Pathogenic |
Lynch syndrome, Mismatch repair cancer syndrome 1 |
| RS63751898 |
HMX1
|
Health Risk |
Pathogenic |
Oculoauricular syndrome, Oculoauricular syndrome |
| RS6407 |
CYP11B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Glucocorticoid-remediable aldosteronism, Deficiency of steroid 11-beta-monooxygenase |
| RS6411 |
CYP11B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Glucocorticoid-remediable aldosteronism, Deficiency of steroid 11-beta-monooxygenase |
| RS6413432 |
CYP2E1
|
Health Risk |
association |
CYP2E1*6 ALLELE, CYP2E1*6 ALLELE |
| RS6413458 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS6413463 |
CDKN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Melanoma-pancreatic cancer syndrome |
| RS6413464 |
CDKN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial melanoma, Hereditary cancer-predisposing syndrome |
| RS6413483 |
GHR
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS6413484 |
GHR
|
Health Risk |
Conflicting classifications of pathogenicity |
Short stature due to partial GHR deficiency, Laron-type isolated somatotropin defect |
| RS6413500 |
IL4R
|
Health Risk |
Conflicting classifications of pathogenicity |
IgE responsiveness, atopic |
| RS6413508 |
NBN
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly, normal intelligence and immunodeficiency |
| RS6434313 |
COL5A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS6445 |
CYP21A2
|
Health Risk |
Pathogenic |
ADRENAL HYPERPLASIA, CONGENITAL |
| RS6447 |
CYP21A2
|
Health Risk |
Conflicting classifications of pathogenicity |
ADRENAL HYPERPLASIA, CONGENITAL |
| RS6449213 |
SLC2A9
|
Health Risk |
association |
Uric acid concentration, serum |
| RS6457452 |
HSPA1B
|
Health Risk |
association |
Chronic obstructive pulmonary disease, Chronic obstructive pulmonary disease |
| RS6467 |
CYP21A2
|
Health Risk |
Conflicting classifications of pathogenicity |
ADRENAL HYPERPLASIA, CONGENITAL |
| RS6471 |
CYP21A2
|
Health Risk |
Pathogenic/Likely pathogenic |
ADRENAL HYPERPLASIA, CONGENITAL |
| RS6471482 |
CNGB3
|
Health Risk |
Pathogenic |
Achromatopsia 3, Achromatopsia 3 |
| RS6475 |
CYP21A2
|
Health Risk |
Pathogenic |
ADRENAL HYPERPLASIA, CONGENITAL |
| RS6476 |
CYP21A2
|
Health Risk |
Conflicting classifications of pathogenicity |
ADRENAL HYPERPLASIA, CONGENITAL |
| RS6493311 |
SLC12A1
|
Health Risk |
Pathogenic |
— |
| RS650616 |
PINK1
|
Health Risk |
Uncertain risk allele |
Leprosy, susceptibility to |
| RS6535454 |
COQ2
|
Health Risk |
Conflicting classifications of pathogenicity |
Coenzyme Q10 deficiency, primary |
| RS6548238 |
-
|
Health Risk |
risk factor |
Obesity, Obesity |
| RS655423 |
INPPL1
|
Health Risk |
Pathogenic |
Opsismodysplasia, Opsismodysplasia |
| RS659366 |
UCP2
|
Health Risk |
risk factor |
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 4, BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 4 |
| RS661 |
PSEN1
|
Health Risk |
Pathogenic |
Alzheimer disease 3, Pick disease |
| RS66468541 |
HSPD1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 13, Hereditary spastic paraplegia 13 |
| RS66469337 |
OTC
|
Health Risk |
Conflicting classifications of pathogenicity |
Ornithine carbamoyltransferase deficiency, Ornithine carbamoyltransferase deficiency |
| RS66489346 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS66490707 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta with normal sclerae |
| RS66492417 |
ABCC6
|
Health Risk |
Pathogenic |
Autosomal recessive inherited pseudoxanthoma elasticum, Autosomal recessive inherited pseudoxanthoma elasticum |
| RS66494876 |
COL1A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Osteogenesis imperfecta, perinatal lethal |
| RS66500027 |
OTC
|
Health Risk |
Pathogenic |
Ornithine carbamoyltransferase deficiency, Ornithine carbamoyltransferase deficiency |
| RS66507857 |
COL1A2
|
Health Risk |
Pathogenic |
— |
| RS66511271 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta, Osteogenesis imperfecta type I |
| RS66512766 |
OTC
|
Health Risk |
Likely pathogenic |
— |
| RS66516450 |
COL1A2
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS66521141 |
OTC
|
Health Risk |
Pathogenic |
Ornithine carbamoyltransferase deficiency, Ornithine carbamoyltransferase deficiency |
| RS66523073 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type III, COL1A1-related disorder |
| RS66527965 |
COL1A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Osteogenesis imperfecta, type III/IV |
| RS66539573 |
OTC
|
Health Risk |
Likely pathogenic |
Ornithine carbamoyltransferase deficiency, Ornithine carbamoyltransferase deficiency |
| RS66547671 |
COL1A2
|
Health Risk |
Likely pathogenic |
— |
| RS66550389 |
OTC
|
Health Risk |
Pathogenic |
Ornithine carbamoyltransferase deficiency, Ornithine carbamoyltransferase deficiency |
| RS66555264 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, 7 conditions |
| RS66556380 |
OTC
|
Health Risk |
Pathogenic |
Ornithine carbamoyltransferase deficiency, Ornithine carbamoyltransferase deficiency |
| RS66564822 |
OTC
|
Health Risk |
Pathogenic |
— |
| RS6657239 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
ABCA4-related disorder, Retinal dystrophy |
| RS66583685 |
CYP1B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Glaucoma 3A, Glaucoma 3 |
| RS66592376 |
COL1A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Connective tissue disorder, Osteogenesis imperfecta type I |
| RS6660707 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS66612022 |
COL1A2
|
Health Risk |
Pathogenic |
6 conditions, Osteogenesis imperfecta with normal sclerae |
| RS66614512 |
GBP1
|
Health Risk |
Likely pathogenic |
Neutrophil inclusion bodies, Neutrophil inclusion bodies |
| RS66616070 |
ABCC6
|
Health Risk |
Likely pathogenic |
Autosomal recessive inherited pseudoxanthoma elasticum, Autosomal recessive inherited pseudoxanthoma elasticum |
| RS66619856 |
COL1A2
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta, perinatal lethal |
| RS66620415 |
NPC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Niemann-Pick disease, type C1 |
| RS66626662 |
OTC
|
Health Risk |
Pathogenic |
Ornithine carbamoyltransferase deficiency, Ornithine carbamoyltransferase deficiency |
| RS66642398 |
OTC
|
Health Risk |
Likely pathogenic |
Ornithine carbamoyltransferase deficiency, Ornithine carbamoyltransferase deficiency |
| RS66656800 |
OTC
|
Health Risk |
Pathogenic |
Ornithine carbamoyltransferase deficiency, Squamous cell carcinoma of the head and neck |
| RS6666 |
PRSS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary pancreatitis, Hereditary pancreatitis |
| RS66664580 |
COL1A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Osteogenesis imperfecta type I, 8 conditions |
| RS66677059 |
OTC
|
Health Risk |
Pathogenic |
Ornithine carbamoyltransferase deficiency, Ornithine carbamoyltransferase deficiency |
| RS66693137 |
OTC
|
Health Risk |
Pathogenic |
Ornithine carbamoyltransferase deficiency, Ornithine carbamoyltransferase deficiency |
| RS66721653 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta with normal sclerae, dominant form |
| RS66724222 |
OTC
|
Health Risk |
Likely pathogenic |
Ornithine carbamoyltransferase deficiency, Ornithine carbamoyltransferase deficiency |
| RS6672843 |
SDCCAG8
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome 16, Senior-Loken syndrome 7 |
| RS66737144 |
OTC
|
Health Risk |
Pathogenic |
Ornithine carbamoyltransferase deficiency, Nonpapillary renal cell carcinoma |
| RS66741318 |
OTC
|
Health Risk |
Pathogenic |
Ornithine carbamoyltransferase deficiency, Ornithine carbamoyltransferase deficiency |
| RS66761141 |
COL1A1
|
Health Risk |
Likely pathogenic |
— |
| RS66773001 |
COL1A2
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS667773 |
PAX6
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant keratitis, Aniridia 1 |
| RS66785829 |
ANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Familial dilated cardiomyopathy and peripheral neuropathy |
| RS66792339 |
ANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiac arrhythmia, Long QT syndrome |
| RS6681 |
MGST3
|
Health Risk |
association |
Pulmonary disease, chronic obstructive |
| RS66820119 |
COL1A2
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, arthrochalasia type |
| RS6682046 |
MPZ
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease dominant intermediate D |
| RS66851495 |
OTC
|
Health Risk |
Likely pathogenic |
Ornithine carbamoyltransferase deficiency, Ornithine carbamoyltransferase deficiency |
| RS66864704 |
ABCC6
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive inherited pseudoxanthoma elasticum, Autosomal recessive inherited pseudoxanthoma elasticum |
| RS66867430 |
OTC
|
Health Risk |
Pathogenic |
Ornithine carbamoyltransferase deficiency, Ornithine carbamoyltransferase deficiency |
| RS66876876 |
SCN1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome 5, Generalized epilepsy with febrile seizures plus |
| RS66883877 |
COL1A2
|
Health Risk |
Pathogenic |
Dentinogenesis imperfecta, Ehlers-Danlos syndrome |
| RS66898362 |
ABCC2
|
Health Risk |
Pathogenic |
ABCC2-related disorder, Dubin-Johnson syndrome |
| RS6690005 |
CYP4Z1
|
Health Risk |
association |
Pulmonary disease, chronic obstructive |
| RS66913554 |
ABCC6
|
Health Risk |
Pathogenic |
Autosomal recessive inherited pseudoxanthoma elasticum, Autosomal recessive inherited pseudoxanthoma elasticum |
| RS66929517 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta, perinatal lethal |
| RS66929519 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS6697155 |
CENPF
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS66999265 |
COL1A2
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |